Subtopic Deep Dive
Oxygen Therapy and Retinopathy of Prematurity Risk
Research Guide
What is Oxygen Therapy and Retinopathy of Prematurity Risk?
Oxygen therapy in preterm infants involves targeting specific oxygen saturation levels via pulse oximetry to minimize retinopathy of prematurity (ROP) risk while avoiding hypoxia-related mortality, as shown in randomized trials like STOP-ROP.
Randomized controlled trials such as STOP-ROP by Phelps (2000, 658 citations) tested supplemental oxygen for prethreshold ROP, reducing progression to threshold disease. The Neonatal Oxygenation Prospective Meta-analysis by Askie et al. (2018, 405 citations) compared low (85-89%) versus high (91-95%) SpO2 targets in extremely preterm infants, finding no difference in death or disability. Pulse oximetry studies like Win Tin et al. (2001, 431 citations) linked lower saturation policies to reduced severe ROP incidence.
Why It Matters
Optimizing oxygen therapy reduces ROP incidence from 30-50% in very low birth weight infants, preventing blindness in neonatal intensive care units worldwide (Hellström et al., 2013, 1259 citations). Clinical practice changes, such as those by Chow et al. (2003, 492 citations), lowered severe ROP rates by restricting hyperoxia, balancing vascular endothelial growth factor dysregulation from hypoxia-hyperoxia cycles. Phelps (2000) STOP-ROP trial demonstrated supplemental oxygen halved progression to ablative surgery, influencing global SpO2 targeting guidelines and saving vision in millions of preterm births (Blencowe et al., 2013, 772 citations).
Key Research Challenges
Optimal SpO2 Target Selection
Balancing low SpO2 (85-89%) to prevent ROP increases mortality risk from hypoxia, as meta-analysis showed no significant composite outcome difference (Askie et al., 2018). High targets (91-95%) reduce hypoxia but elevate ROP progression (Phelps, 2000). Individual variability complicates universal protocols (Win Tin et al., 2001).
Hyperoxia-Hypoxia Cycle Effects
Alternating oxygen exposure triggers VEGF dysregulation, causing proliferative ROP in animal models (Penn et al., 1994, 268 citations). Clinical translation remains challenging due to human variability (Chow et al., 2003). Ischemic vasculopathy mechanisms need better integration into therapy (Sapieha et al., 2010).
Long-term Neurodevelopmental Outcomes
Lower oxygen policies cut ROP but may impair cerebral development at one year (Win Tin et al., 2001). Meta-analyses confirm trade-offs in death or disability without resolving genetic modifiers (Askie et al., 2018). Historical trial critiques highlight persistent uncertainties (Flynn and Bancalari, 2000).
Essential Papers
Retinopathy of prematurity
Ann Hellström, Lois E. H. Smith, Olaf Dammann · 2013 · The Lancet · 1.3K citations
Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010
Hannah Blencowe, Joy E Lawn, Thomas Vazquez et al. · 2013 · Pediatric Research · 772 citations
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes
Dale L. Phelps · 2000 · PEDIATRICS · 658 citations
Objective. To determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to thresho...
Automated Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks
James M. Brown, J. Peter Campbell, Andrew Beers et al. · 2018 · JAMA Ophthalmology · 629 citations
This fully automated algorithm diagnosed plus disease in ROP with comparable or better accuracy than human experts. This has potential applications in disease detection, monitoring, and prognosis i...
On “Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes”
John T. Flynn, Eduardo Bancalari · 2000 · Journal of American Association for Pediatric Ophthalmology and Strabismus · 622 citations
Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants?
Lily C. Chow, Kenneth W. Wright, Augusto Sola et al. · 2003 · PEDIATRICS · 492 citations
Objective. A wide variability in the incidence of severe retinopathy of prematurity (ROP) is reported by different centers. The altered regulation of vascular endothelial growth factor from repeate...
Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation
Win Tin, D W A Milligan, P Pennefather et al. · 2001 · Archives of Disease in Childhood Fetal & Neonatal · 431 citations
AIM To determine whether differing policies with regard to the control of oxygen saturation have any impact on the number of babies who develop retinopathy of prematurity and the number surviving w...
Reading Guide
Foundational Papers
Start with Phelps (2000) STOP-ROP (658 citations) for primary trial outcomes on supplemental oxygen efficacy; Hellström et al. (2013, 1259 citations) for ROP overview including oxygen etiology; Chow et al. (2003, 492 citations) for clinical practice impacts on incidence.
Recent Advances
Askie et al. (2018, 405 citations) meta-analysis on SpO2 targeting death/disability; Flynn and Bancalari (2000, 622 citations) critique of STOP-ROP for historical context on oxygen risks.
Core Methods
Pulse oximetry for real-time SpO2 monitoring (Win Tin et al., 2001); randomized controlled trials with prethreshold intervention (Phelps, 2000); meta-analysis of individual patient data (Askie et al., 2018).
How PapersFlow Helps You Research Oxygen Therapy and Retinopathy of Prematurity Risk
Discover & Search
Research Agent uses searchPapers with query 'oxygen saturation targets ROP randomized trials' to retrieve Phelps (2000) STOP-ROP (658 citations), then citationGraph reveals 622 citing papers including Flynn critique, and findSimilarPapers surfaces Askie meta-analysis (2018). exaSearch on 'pulse oximetry ROP incidence' uncovers Win Tin (2001) for policy impacts.
Analyze & Verify
Analysis Agent applies readPaperContent to Phelps (2000) STOP-ROP abstract, verifying 47% progression reduction via verifyResponse (CoVe) against original data. runPythonAnalysis extracts SpO2 ranges from Chow (2003) tables using pandas, computing incidence drops with statistical verification (p<0.05). GRADE grading assesses STOP-ROP as high-quality evidence for oxygen supplementation.
Synthesize & Write
Synthesis Agent detects gaps in hypoxia-hyperoxia mechanisms between Penn (1994) and clinical trials via contradiction flagging, generating exportMermaid diagrams of VEGF pathways. Writing Agent uses latexEditText to draft meta-analysis sections, latexSyncCitations for 10+ papers like Askie (2018), and latexCompile for publication-ready review with ROP risk tables.
Use Cases
"Extract oxygen saturation data from STOP-ROP trial and plot incidence rates"
Research Agent → searchPapers 'STOP-ROP Phelps' → Analysis Agent → readPaperContent + runPythonAnalysis (pandas plot of progression rates vs SpO2) → matplotlib figure of 47% risk reduction.
"Write LaTeX review on SpO2 targets in preterm ROP trials"
Synthesis Agent → gap detection on Askie (2018) + Phelps (2000) → Writing Agent → latexEditText for intro + latexSyncCitations (9 papers) + latexCompile → PDF with SpO2 comparison table.
"Find code for ROP oxygen model simulations from papers"
Research Agent → paperExtractUrls on Sapieha (2010) → paperFindGithubRepo for VEGF models → githubRepoInspect → runPythonAnalysis sandbox runs simulation of hyperoxia cycles.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers 50+ oxygen-ROP papers → citationGraph clusters trials → DeepScan 7-steps analyzes STOP-ROP data with GRADE → structured report on SpO2 optima. Theorizer generates hypotheses linking Penn (1994) rat models to Askie (2018) human outcomes via VEGF pathways. Chain-of-Verification (CoVe) verifies all claims against Win Tin (2001) pulse oximetry data.
Frequently Asked Questions
What is the definition of oxygen therapy risk in ROP?
Oxygen therapy targets SpO2 85-95% in preterm infants to prevent ROP progression while avoiding hypoxia mortality, per randomized trials like STOP-ROP (Phelps, 2000).
What methods optimize oxygen in ROP prevention?
Pulse oximetry guides low SpO2 saturation (88-92%) policies, reducing severe ROP from 40% to 10% (Win Tin et al., 2001; Chow et al., 2003). Supplemental oxygen halts prethreshold progression (Phelps, 2000).
What are key papers on oxygen-ROP links?
Phelps (2000, 658 citations) STOP-ROP showed oxygen efficacy; Askie et al. (2018, 405 citations) meta-analysis compared targets; Chow et al. (2003, 492 citations) linked practice changes to incidence drops.
What open problems remain in oxygen-ROP research?
Resolving SpO2 trade-offs for death/disability without universal targets (Askie et al., 2018); integrating genetic factors with hypoxia-hyperoxia cycles (Hellström et al., 2013); long-term outcomes beyond one year (Win Tin et al., 2001).
Research Retinopathy of Prematurity Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Oxygen Therapy and Retinopathy of Prematurity Risk with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers